SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Feb-19 1:35 PM View: | EnteroMedics, Inc. (RSLS) | 01-Feb-19 | Purchase | 1,192,000 | -- | -- | (100%) 1.19M to 0.51K | |
04-Feb-19 1:35 PM View: | EnteroMedics, Inc. (RSLS) | 31-Jan-19 | Private Purchase | 10,301 | $0.27 | $2,815.26 | < 1% 1.18M to 1.19M | (100%) |
31-Jan-19 10:43 AM View: | EnteroMedics, Inc. (RSLS) | 30-Jan-19 | Private Purchase | 48,000 | $0.28 | $13,440.00 | 4% 1.13M to 1.18M | (100%) |
31-Jan-19 10:43 AM View: | EnteroMedics, Inc. (RSLS) | 29-Jan-19 | Private Purchase | 12,200 | $0.28 | $3,390.38 | 1% 1.12M to 1.13M | (100%) |
28-Jan-19 3:46 PM View: | EnteroMedics, Inc. (RSLS) | 25-Jan-19 | Private Purchase | 15,595 | $0.27 | $4,237.16 | 1% 1.11M to 1.12M | (100%) |
28-Jan-19 3:46 PM View: | EnteroMedics, Inc. (RSLS) | 24-Jan-19 | Private Purchase | 6,190 | $0.25 | $1,578.45 | < 1% 1.1M to 1.11M | (100%) |
24-Jan-19 10:56 AM View: | EnteroMedics, Inc. (RSLS) | 22-Jan-19 | Private Purchase | 5,766 | $0.28 | $1,609.29 | < 1% 1.09M to 1.1M | (100%) |
22-Jan-19 9:39 AM View: | EnteroMedics, Inc. (RSLS) | 18-Jan-19 | Private Purchase | 24,334 | $0.28 | $6,786.75 | 2% 1.07M to 1.09M | (100%) |
22-Jan-19 9:39 AM View: | EnteroMedics, Inc. (RSLS) | 17-Jan-19 | Private Purchase | 52 | $0.28 | $14.56 | < 1% 1.07M to 1.07M | (100%) |
17-Jan-19 11:03 AM View: | EnteroMedics, Inc. (RSLS) | 16-Jan-19 | Private Purchase | 26,661 | $0.27 | $7,172.16 | 3% 1.04M to 1.07M | (100%) |
17-Jan-19 11:03 AM View: | EnteroMedics, Inc. (RSLS) | 15-Jan-19 | Private Purchase | 167,760 | $0.24 | $39,440.40 | 19% 875.65K to 1.04M | (100%) |
27-Apr-18 10:00 PM View: | Rosetta Genomics Ltd. (ROSGQ) | 26-Apr-18 | Purchase | 7,085 | $0.35 | $2,479.75 | < 1% 934.61K to 941.69K | |
19-Mar-18 9:40 AM View: | Rosetta Genomics Ltd. (ROSGQ) | 16-Mar-18 | Purchase | 64,298 | $0.43 | $27,728.20 | 7% 870.31K to 934.61K | |
16-Mar-18 10:28 AM View: | Rosetta Genomics Ltd. (ROSGQ) | 15-Mar-18 | Purchase | 46,570 | $0.42 | $19,574.10 | 6% 823.74K to 870.31K | |
16-Mar-18 10:28 AM View: | Rosetta Genomics Ltd. (ROSGQ) | 14-Mar-18 | Purchase | 73,191 | $0.42 | $30,816.70 | 10% 750.55K to 823.74K | |
14-Mar-18 3:42 PM View: | Rosetta Genomics Ltd. (ROSGQ) | 13-Mar-18 | Purchase | 37,319 | $0.42 | $15,683.30 | 5% 713.23K to 750.55K | |
14-Mar-18 3:42 PM View: | Rosetta Genomics Ltd. (ROSGQ) | 12-Mar-18 | Purchase | 138,509 | $0.42 | $57,661.70 | 24% 574.72K to 713.23K | |
17-Apr-14 4:17 PM View: | Akari Therapeutics Plc (AKTX) | 15-Apr-14 | Market Purchase | 17,100 | $5.00 | $85,500.00 | 2% 760.93K to 778.03K | (96%) |
17-Apr-14 4:17 PM View: | Akari Therapeutics Plc (AKTX) | 14-Apr-14 | Market Purchase | 3,000 | $5.21 | $15,630.00 | < 1% 757.93K to 760.93K | (96%) |
11-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 11-Apr-14 | Market Purchase | 100 | $5.15 | $515.00 | < 1% 757.83K to 757.93K | (96%) |
11-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 10-Apr-14 | Market Purchase | 1,400 | $5.25 | $7,350.00 | < 1% 756.43K to 757.83K | (96%) |
11-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 09-Apr-14 | Market Purchase | 1,075 | $5.51 | $5,923.25 | < 1% 755.36K to 756.43K | (96%) |
08-Apr-14 4:05 PM View: | Akari Therapeutics Plc (AKTX) | 08-Apr-14 | Market Purchase | 35,500 | $5.36 | $190,280.00 | 5% 719.86K to 755.36K | (96%) |
08-Apr-14 4:05 PM View: | Akari Therapeutics Plc (AKTX) | 07-Apr-14 | Market Purchase | 20,654 | $5.71 | $117,840.00 | 3% 699.2K to 719.86K | (96%) |
08-Apr-14 4:05 PM View: | Akari Therapeutics Plc (AKTX) | 04-Apr-14 | Market Purchase | 12,250 | $6.07 | $74,400.00 | 2% 686.95K to 699.2K | (96%) |
02-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 02-Apr-14 | Market Purchase | 2,500 | $6.15 | $15,375.00 | < 1% 1.35M to 1.36M | (97%) |
02-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 01-Apr-14 | Market Purchase | 15,371 | $6.10 | $93,805.50 | 1% 1.34M to 1.35M | (96%) |
02-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 31-Mar-14 | Market Purchase | 7,936 | $6.35 | $50,393.60 | < 1% 1.33M to 1.34M | (97%) |
27-Mar-14 4:15 PM View: | Akari Therapeutics Plc (AKTX) | 27-Mar-14 | Market Purchase | 1,700 | $6.61 | $11,237.00 | < 1% 657.04K to 658.74K | (97%) |
27-Mar-14 4:15 PM View: | Akari Therapeutics Plc (AKTX) | 26-Mar-14 | Market Purchase | 14,200 | $6.66 | $94,619.00 | 2% 642.84K to 657.04K | (97%) |
27-Mar-14 4:15 PM View: | Akari Therapeutics Plc (AKTX) | 25-Mar-14 | Market Purchase | 303 | $6.90 | $2,090.70 | < 1% 642.54K to 642.84K | (97%) |
24-Mar-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 24-Mar-14 | Market Purchase | 2,400 | $6.71 | $16,104.00 | < 1% 640.14K to 642.54K | (97%) |
24-Mar-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 21-Mar-14 | Market Purchase | 4,900 | $6.83 | $33,467.00 | < 1% 635.24K to 640.14K | (97%) |
24-Mar-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 20-Mar-14 | Market Purchase | 3,800 | $6.90 | $26,220.00 | < 1% 631.44K to 635.24K | (97%) |
02-Apr-14 4:04 PM View: | Akari Therapeutics Plc (AKTX) | 17-Mar-14 | Market Purchase | 2,400 | $6.65 | $15,960.00 | < 1% 1.33M to 1.33M | (97%) |